Publication related to RSI or an RSI staff member

Interventions for COVID-19 Vaccine Hesitancy: A Systematic Review and Narrative Synthesis.

Vaccines effectively protect against COVID-19, but vaccine hesitancy and refusal hinder vaccination rates. This systematic review aimed to (1) review and describe current interventions for addressing COVID-19 vaccine hesitancy/refusal and (2) assess whether these interventions are effective for increasing vaccine uptake. The protocol was registered prospectively on PROSPERO and comprehensive search included Medline, Embase, CINAHL, PsycInfo, and Web of Science databases. Only studies that evaluated the effectiveness of non-financial interventions to address COVID-19 vaccine hesitancy were included, while those focusing intentions or financial incentive were excluded. Risk of bias for all included studies was evaluated using Cochrane risk of bias tools. In total, six articles were included in the review (total participants n = 200,720). A narrative synthesis was performed due to the absence of common quantitative metrics. Except for one randomized controlled trial, all studies reported that interventions were effective, increasing COVID-19 vaccination rates. However, non-randomized studies were subject to confounding biases. Evidence on the effectiveness of COVID-19 vaccine hesitancy interventions remains limited and further evidence is needed for the development of clear guidance on effective interventions to increase vaccine uptake.

Authors

  • Terrell, Rowan, Terrell R, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1S 5B6, Canada.

  • Alami, Abdallah, Alami A, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1S 5B6, Canada.

  • Krewski, Daniel, Krewski D, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1S 5B6, Canada.; Risk Sciences International, Ottawa, ON K1P 5J6, Canada.

YEAR OF PUBLICATION: 2023
SOURCE: Int J Environ Res Public Health. 2023 Jun 8;20(12):6082. doi: 10.3390/ijerph20126082.
JOURNAL TITLE ABBREVIATION: Int J Environ Res Public Health
JOURNAL TITLE: International journal of environmental research and public health
ISSN: 1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)
VOLUME: 20
ISSUE: 12
PLACE OF PUBLICATION: Switzerland
ABSTRACT:
Vaccines effectively protect against COVID-19, but vaccine hesitancy and refusal hinder vaccination rates. This systematic review aimed to (1) review and describe current interventions for addressing COVID-19 vaccine hesitancy/refusal and (2) assess whether these interventions are effective for increasing vaccine uptake. The protocol was registered prospectively on PROSPERO and comprehensive search included Medline, Embase, CINAHL, PsycInfo, and Web of Science databases. Only studies that evaluated the effectiveness of non-financial interventions to address COVID-19 vaccine hesitancy were included, while those focusing intentions or financial incentive were excluded. Risk of bias for all included studies was evaluated using Cochrane risk of bias tools. In total, six articles were included in the review (total participants n = 200,720). A narrative synthesis was performed due to the absence of common quantitative metrics. Except for one randomized controlled trial, all studies reported that interventions were effective, increasing COVID-19 vaccination rates. However, non-randomized studies were subject to confounding biases. Evidence on the effectiveness of COVID-19 vaccine hesitancy interventions remains limited and further evidence is needed for the development of clear guidance on effective interventions to increase vaccine uptake.
LANGUAGE: eng
DATE OF PUBLICATION: 2023 Jun 8
DATE OF ELECTRONIC PUBLICATION: 20230608
DATE COMPLETED: 20230629
DATE REVISED: 20250626
MESH DATE: 2023/06/29 06:43
EDAT: 2023/06/28 06:42
STATUS: MEDLINE
PUBLICATION STATUS: epublish
LOCATION IDENTIFIER: 10.3390/ijerph20126082 [doi] 6082
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski